Actelion

Actelion is a pharmaceutical company that specializes in the discovery, development, and commercialization of innovative drugs for diseases with significant unmet medical needs. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion's products are sold in over 100 countries worldwide.

History[edit | edit source]

Actelion was founded in 1997 by a group of scientists and clinicians from Roche, a multinational healthcare company. The founders were driven by the desire to develop innovative drugs for diseases with significant unmet medical needs. Since its inception, Actelion has grown to become a leading player in the global pharmaceutical industry.

Products[edit | edit source]

Actelion's product portfolio includes drugs for the treatment of pulmonary arterial hypertension, Gaucher's disease, Digital ulcers, and Type 1 Gaucher disease. The company's flagship product, Tracleer, is a dual endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension.

Research and Development[edit | edit source]

Actelion's research and development efforts are focused on discovering and developing innovative drugs for diseases with significant unmet medical needs. The company's R&D activities are guided by a deep understanding of the underlying disease mechanisms and a commitment to scientific excellence.

Partnerships and Collaborations[edit | edit source]

Actelion has a history of successful partnerships and collaborations with other pharmaceutical companies, academic institutions, and research organizations. These partnerships have enabled Actelion to expand its product portfolio and strengthen its R&D capabilities.

See Also[edit | edit source]

Actelion Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.